To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
The FDA has identified this as a Class I recall, the most serious type of recall. There have been 13 reported injuries. There have been no reports of death. Get the Strategy to Trade Pre-Fed Setups ...
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris ...
Medical Device Network on MSN
FDA tags Becton, Dickinson and Company infusion software recall as Class I
Problematic software has been the cause of multiple infusion pump recalls in the medical device industry over the past few years.
FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the ...
Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company (BDX), a New Jersey-based medical ...
Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson BDX.N is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's CAH.N ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results